Co-administration of internalized peptide-linked drug and anti-inflammatory drug

摘要

Provided is a drug for inhibiting cerebral ischemia caused by endovascular surgery. SOLUTION: An endogenous drug that inhibits the binding of post-synaptic thickened part-95 protein (PSD-95) to NMDAR2B, which is used in combination with a mast cell degranulation inhibitor that blocks an internalized peptide-induced inflammatory response Peptide-linked pharmacological agent. Preferably, the mast cell degranulation inhibitor is rhodoxamide. [Selection diagram] Fig. 15